000 | 01686 a2200433 4500 | ||
---|---|---|---|
005 | 20250514014611.0 | ||
264 | 0 | _c20011219 | |
008 | 200112s 0 0 eng d | ||
022 | _a0022-1899 | ||
024 | 7 |
_a10.1086/324005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOstrowski, M A | |
245 | 0 | 0 |
_aQuantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. _h[electronic resource] |
260 |
_bThe Journal of infectious diseases _cNov 2001 |
||
300 |
_a1268-78 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aCD4 Lymphocyte Count |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aGene Products, gag _ximmunology |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-gamma _xanalysis |
650 | 0 | 4 |
_aInterleukin-10 _xanalysis |
650 | 0 | 4 | _aViral Load |
700 | 1 | _aGu, J X | |
700 | 1 | _aKovacs, C | |
700 | 1 | _aFreedman, J | |
700 | 1 | _aLuscher, M A | |
700 | 1 | _aMacDonald, K S | |
773 | 0 |
_tThe Journal of infectious diseases _gvol. 184 _gno. 10 _gp. 1268-78 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1086/324005 _zAvailable from publisher's website |
999 |
_c11596901 _d11596901 |